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Extracellular ATPMediates FasL-induced Necrosis of Lymphoid Cells Via
P2X7 Activation
Mauricio Henriquez, Andrew Quest.
FONDAP Center for Molecular Studies of the Cell (CEMC),
Institute of Biomedical Sciences (ICBM), Faculty de Medicine,
University of Chile, Santiago, Chile.
We demonstrated previously that FasL triggers both necrotic and apoptotic
death in lymphoid cells. The execution of apoptosis was linked to activation
of caspase-8 and caspase-3, while necrotic cell death required only activation
of caspase-8 associated with delayed increases in ceramides. However, the pre-
cise signaling mechanisms involved in deciding between FasL-induced apopto-
tic or necrotic cell death in lymphoid cells remained unknown. On the other
hand, many studies have implicated extracellular ATP as a mediator of cell
death by necrosis, as well as apoptosis. In particular, ATP-dependent activation
of purinergic P2X7 receptors has been suggested to trigger both forms of cell
death. Hence, the objective here was to evaluate whether ATP/P2X7 partici-
pated in cell death induced by FasL in lymphoid cells. Flow cytometric analysis
following staining with propidium iodide, in human Jurkat cells demonstrated
that oxidized ATP, a specific P2X7 antagonist, selectively inhibited necrotic,
but not apoptotic cell death induced by Fas-L. ATP, the physiological P2X7
ligand, was released from Jurkat cells following incubation with FasL. Further-
more, FasL-stimulated intracellular calcium-transients in Jurkat cells (mea-
sured using the Fluo3-AM probe) were blocked either when extracellular cal-
cium was chelated or when cells were preincubated with oxidized ATP. The
presence of P2X7 receptors in Jurkat cells was corroborated by Western blot-
ting.
This study represents the first demonstration of cross-talk between the two cell
death receptors Fas and P2X7 in lymphoid cells.
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T Cell Receptor Regulation Of Fas-mediated Apoptotic Calcium Release
Askar M. Akimzhanov, Xinmin Wang, Darren Boehning.
University of Texas Medical Branch, Galveston, TX, USA.
Although alterations in calcium levels are known to play an important role in
a variety of physiological processes, only in past few years has the role of cal-
cium signaling in regulation of apoptosis been well recognized. It has been
shown that apoptotic stimuli provoke rapid elevation of cytosolic calcium con-
centration, which in turn orchestrates the release and activation of multiple
pro-apoptotic factors. Our previous results in T cells demonstrated that Fas-
mediated apoptosis requires calcium release, which was dependent upon
phospholipase C-g1 (PLC-g1) activation and calcium release from inositol
1,4,5-trisphosphate receptor (IP3R) channels. Here, we show that PLC-g1 acti-
vation after Fas receptor ligation requires canonical components of the T cell
receptor complex. Specifically, the active form of the Src family tyrosine ki-
nase Lck and PLC-g1 become associated with the death-inducing signaling
complex (DISC) in a stimulus-dependent manner. We found that Lck activates
PLC-g1 indirectly via Zap70 tyrosine kinase and other members of the T cell
receptor signaling pathway. Moreover, in absence of a functional T cell recep-
tor complex, Fas stimulation failed to induce calcium release. This led to sig-
nificantly inhibited effector caspase activation and delayed cell death. These
findings strongly suggest a vital interplay between Fas and the T cell receptor
complex, which has significant implications for T cell regulation.
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Novel Kþ Channel Blocker Induces Apoptosis Via Ca2þ Release From ER
Stores
Elena Zaks-Makhina1, Chandra Vignere1, Vicenta Salvador-Recatala2,
Edwin S. Levitan1.
1University of Pittsburgh, Pittsburgh, PA, USA, 2University of Pennsylvania,
Philadelphia, PA, USA.
In search of novel Kþ channel modulators we have undertaken HTS of chem-
ical libraries. The primary screen using yeast whose growth in low [Kþ] me-
dium depends on expression of the inwardly rectifying Kþ channel Kir2.1
was followed by Kþ current measurements in mammalian cells. One of the
identified compounds, 22G ({1-[3-(4-chloro-phenyl)-adamantan-1-yl]-ethyl}-
(1-ethyl-piperidin-4-yl)-amine), inhibits Kir2.1-dependent yeast growth, de-
creases 86Rbþ flux via Kir2.1 and acutely blocks the whole-cell Kir2.1 current
(EC50¼25 mM) in transfected HEK293 cells. As a part of specificity character-
ization of 22G, we examined its effect on 86Rbþ efflux via recombinant and
native Ca2þ-activated Kþ channel (IKCa) in HEK293 cells and IEC-6 entero-
cytes, respectively. Surprisingly, 22G induced rapid Kþ efflux via IKCa.
Because previously we have established that IKCa-dependent Kþ efflux is es-
sential for apoptosis, we tested whether 22G is capable of inducing apoptosis.
When applied at 25 mM for 10 min, 22G caused activation of caspases in 90%of IEC-6 cells, as determined by staining with the fluorescent pan-caspase in-
hibitor FAM-VAD-FMK. Blockade of 22G-induced Kþ current by the IKCa
inhibitor clotrimazole prevented the induction of apoptosis. Thus, 22G is a po-
tent inducer of IKCa-mediated apoptosis. To test whether 22G activates pro-ap-
optotic IKCa current by elevating the cytosolic [Ca2þ], we measured Ca2þ
levels in 22G-treated HEK293, CHO and IEC-6 cells loaded with the Ca2þ in-
dicator fluo-4. At 50 mM, 22G induced increase in cytosolic Ca2þ in Ca2þ-free
solution in all three cell lines. Depletion of ER Ca2þ stores with thapsigargin
and cyclopiazonic acid abolished 22G-induced surge of cytosolic [Ca2þ] and
IKCa current. Therefore, 22G activates IKCa current via Ca2þ release from
ER stores. We suggest using compound 22G as a reliable apoptogen, a tool
for modulation of intracellular [Ca2þ] and inhibitor of Kir2.1 current in
patch-clamp experiments.
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The Amino-terminal Peptide Of Bax Perturbs Intracellular Ca2þ Homeo-
stasis To Enhance Apoptosis In Prostate Cancer Cells
Na Li, Peihui Lin, Chuanxi Cai, Zui Pan, Noah Weisleder, Jianjie Ma.
UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Targeting the interconnected cellular pathways controlling apoptosis and regu-
lation of Ca2þ homeostasis are two avenues for treatment of human cancers.
During apoptosis, proteolytic cleavage of Bax at the amino-terminus generates
a truncated Bax of ~18 kDa (p18Bax) and an amino-terminal peptide of ~3 kDa
(p3Bax). Extensive studies have shown that p18Bax behaves like a BH3 protein
with enhanced pro-apoptotic function over the full-length Bax (p21Bax), little
is known about the function of p3Bax in apoptosis. We have previously shown
that Bax and Ca2þ synergistically amplifying apoptosis signaling (Pan, et al. J
Biol Chem 276: 32257, 2001), and that store-operated Ca2þ entry (SOCE) con-
tributes to Bax-mediated apoptosis in prostate cancer cells (Li, et al. J Cell
Physiol 216: 172, 2008). Here we test if p3Bax can contribute to regulation
of Ca2þ signaling during apoptosis, through a membrane penetrating peptide
(TAT) to facilitate delivery of recombinant p3Bax into NRP-154 cells, a pros-
tate epithelial cell line with tumorigenic capacity. We find that TAT-p3Bax
fusion peptide can enhance thapsigargin-induced apoptosis in NRP-154 cells,
elevate SOCE activity and increase IP3 sensitive intracellular Ca
2þ stores.
Our data indicates that p3Bax can modulate the entry of extracellular Ca2þ,
and thus regulate the amplification of apoptosis in prostate cancer cells. An-
other unique observation of this study is that TAT-p3Bax is not toxic to
NRP-Bax cells under resting conditions, it only enhances the process of apopto-
sis initiated by exposure to TG. This is particularly important when considering
the exogenous p3Bax peptide as a therapeutic agent for prostate cancer. In such
a case, p3Bax would not produce cytotoxic effects in cells with normal Ca2þ
homeostasis, it could be used in combination with other cytotoxic agents to am-
plify apoptosis in targeted cancer cells.
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The Anti-apoptotic Mitochondrial Membrane Protein Bcl-2; An Achilles
Heel Of Cancer Cells?
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Escape from programmed cell death, apoptosis, is one of the main hallmarks of
cancer.. The anti-apoptotic protein Bcl-2 belongs to the Bcl-2 protein family,
which function as a major gatekeeper in the mitochondrial pathway. Bcl-2 is
found to a great extent in many breast cancers and is highly involved in the in-
herent resistance to anti-cancer drugs. This protein is mitochondrial membrane-
associated and we will use NMR spectroscopy to provide structural information
of the membrane-mediated mechanism underlying the action of Bcl-2 as a po-
tent inhibitor of cell death.
For this purpose we express currently the full length protein and carry out var-
ious preliminary studies of the membrane dependent behaviour of synthesized
segments of the proteins by a range of biophysical methods ranging from CD
(Circular Dichroism), ATR (Attenuated Total Reflection), Calorimetry to solid
state NMR spectroscopy.At present, we study the impact of the unique BH4 do-
main of the pro-survival Bcl-2 protein on the mitochondrial membranes, since
this interaction seems to be essential to block any apoptotic activation with its
connected pore-formation and cytochrome c release. Our first results reveal that
the BH4 domain requires cardiolipin to be able to convert into an a-helix con-
formation. In contact with neutral membranes, the peptide seems to aggregate
on the surface. Bcl-2’s counterplayer is Bax protein which upon activation tran-
locates to the mitochondrial membrane. In this process the first helix localized
at the N-terminus of Bax (Bax-a1) can act as an addressing sequence, which
upon activation directs the protein from the cytosol towards the mitochondrial
surface. Our biophysical approach provided insight into the molecular
